| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $29K | — |
| Cost of Revenue | $15K | — |
| Gross Profit | $14K | — |
| R&D Expense | $339K | +173.4% |
| SG&A Expense | $1.1M | -19.6% |
| Operating Income | -$1.8M | -11.4% |
| Pre-tax Income | -$4.0M | -121.9% |
| Net Income | -$4.0M | -121.9% |
| EPS (Basic) | -$0.01 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $79K | -64.4% |
| Inventory | $23K | +64.3% |
| Current Assets | $131K | -52.9% |
| Total Assets | $385K | -18.8% |
| Current Liabilities | $1.7M | -45.0% |
| Total Liabilities | $4.5M | +49.6% |
| Stockholders' Equity | -$4.1M | -62.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$785K | -31.5% |
| Investing Cash Flow | -$80K | +14.0% |
| Financing Cash Flow | $719K | -16.9% |
| EPS (Diluted) | -$0.01 | -28.6% |